Unknown

Dataset Information

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit.


ABSTRACT: Ovarian cancer (OC) has the lowest survival rate among gynecologic malignancies. Ectopic lymphocyte aggregates, namely tertiary lymphoid structures (TLSs), have been reported as positive biomarkers for tumor prognosis. However, the related gene signature of tertiary lymphoid structure in ovarian cancer was less understood. Therefore, this study first exhibited the organizational patterns of tertiary lymphoid structure by H&E staining and immunohistochemistry (IHC), and confirmed the improved survival values of tertiary lymphoid structure and quantified tumor-infiltrating lymphocytes (CD20+ B cells and CD8+ T cells) in ovarian cancer patients. Secondly, we collected the genes involved in tertiary lymphoid structure from databases. By the univariate regression analysis,

SUBMITTER: Hou Y 

PROVIDER: S-EPMC9871364 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature